Chemotherapy is cancer treatment that uses drugs to kill cancer cells by preventing them from growing and dividing. These drugs are systemic treatments, meaning that the drugs travel through the ...
LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments to ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
For the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, more than 90% of tumors are thought to have a KRAS mutation. For decades, these mutations were considered “undruggable, ...
Editor’s note: Medical Research Week gives us a chance to recognize the groundbreaking work of scientists whose discoveries have led to new treatments, cures and diagnostic tools for devastating ...
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
PanCAN’s new Chief Scientific and Medical Officer, Anna Berkenblit, MD, MMSc, has nearly 20 years of experience bringing new therapies to patients with cancer. She’s served in leadership roles in ...
Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...
LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...
If you’ve ever had a baby, you may be familiar with jaundice. Jaundice causes the skin and eyes to appear yellow and affects about 60 percent of newborns. While it may be common and is typically ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results